108 related articles for article (PubMed ID: 12504818)
1. Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder.
Saburi Y; Okumura K; Matsui H; Hayashi K; Kamiya H; Takahashi R; Matsubara K; Ito M
Cardiovasc Res; 2003 Jan; 57(1):92-100. PubMed ID: 12504818
[TBL] [Abstract][Full Text] [Related]
2. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency.
Takahashi R; Okumura K; Asai T; Hirai T; Murakami H; Murakami R; Numaguchi Y; Matsui H; Ito M; Murohara T
Cardiovasc Res; 2005 Nov; 68(2):213-23. PubMed ID: 15963478
[TBL] [Abstract][Full Text] [Related]
3. Impact of alpha-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol.
Takahashi R; Okumura K; Matsui H; Saburi Y; Kamiya H; Matsubara K; Asai T; Ito M; Murohara T
Cardiovasc Res; 2003 Jun; 58(3):565-74. PubMed ID: 12798429
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
Asai T; Okumura K; Takahashi R; Matsui H; Numaguchi Y; Murakami H; Murakami R; Murohara T
Cardiovasc Res; 2006 Jun; 70(3):566-77. PubMed ID: 16546150
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency.
Kuwajima M; Lu K; Sei M; Ono A; Hayashi M; Ishiguro K; Ozaki K; Hotta K; Okita K; Murakami T; Miyagawa J; Narama I; Nikaido H; Hayakawa J; Nakajima H; Namba M; Hanafusa T; Matsuzawa Y; Shima K
J Mol Cell Cardiol; 1998 Apr; 30(4):773-81. PubMed ID: 9602426
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant changes in the hypertrophied heart due to energy metabolic disorder.
Kamiya H; Okumura K; Ito M; Matsui H; Saburi Y; Hayashi K; Hayakawa T
Basic Res Cardiol; 2001 Sep; 96(5):431-8. PubMed ID: 11605989
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency.
Yoshimine K; Horiuchi M; Suzuki S; Kobayashi K; Abdul JM; Masuda M; Tomomura M; Ogawa Y; Itoh H; Nakao K; Osame M; Saheki T
J Mol Cell Cardiol; 1997 Feb; 29(2):571-8. PubMed ID: 9140816
[TBL] [Abstract][Full Text] [Related]
8. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency.
Horiuchi M; Yoshida H; Kobayashi K; Kuriwaki K; Yoshimine K; Tomomura M; Koizumi T; Nikaido H; Hayakawa J; Kuwajima M
FEBS Lett; 1993 Jul; 326(1-3):267-71. PubMed ID: 8325377
[TBL] [Abstract][Full Text] [Related]
9. Carnitine transport defect in fibroblasts of juvenile visceral steatosis (JVS) mouse.
Kuwajima M; Lu K; Harashima H; Ono A; Sato I; Mizuno A; Murakami T; Nakajima H; Miyagawa J; Namba M; Hanafusa T; Hayakawa J; Matsuzawa Y; Shima K
Biochem Biophys Res Commun; 1996 Jun; 223(2):283-7. PubMed ID: 8670273
[TBL] [Abstract][Full Text] [Related]
10. Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency.
Jalil A; Horiuchi M; Nomoto M; Kobayashi K; Saheki T
Life Sci; 1999; 64(13):1137-44. PubMed ID: 10210276
[TBL] [Abstract][Full Text] [Related]
11. Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation.
Takahashi R; Asai T; Murakami H; Murakami R; Tsuzuki M; Numaguchi Y; Matsui H; Murohara T; Okumura K
Hypertension; 2007 Sep; 50(3):497-502. PubMed ID: 17664396
[TBL] [Abstract][Full Text] [Related]
12. The signaling pathway of cardiotrophin-1 is not activated in hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice.
Yoshida G; Horiuchi M; Kobayashi K; Jalil MD; Iijima M; Hagihara S; Nagao N; Saheki T
In Vivo; 2000; 14(3):401-5. PubMed ID: 10904873
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of cardiac hypertrophy in carnitine-deficient juvenile visceral steatosis (JVS) mice achieved by lowering dietary lipid.
Jalil MA; Horiuchi M; Wakamatsu M; Li MX; Begum L; Suzuki K; Kobayashi K; Oka T; Saheki T
J Biochem; 2006 Feb; 139(2):263-70. PubMed ID: 16452314
[TBL] [Abstract][Full Text] [Related]
14. Involvement of 1,2-diacylglycerol in improvement of heart function by etomoxir in diabetic rats.
Hayashi K; Okumura K; Matsui H; Murase K; Kamiya H; Saburi Y; Numaguchi Y; Toki Y; Hayakawa T
Life Sci; 2001 Feb; 68(13):1515-26. PubMed ID: 11253168
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitor attenuates cardiac hypertrophy due to energy metabolic disorder.
Kamiya H; Okumura K; Ito M; Saburi Y; Tomida T; Hayashi K; Matsui H; Hayakawa T
Can J Cardiol; 2001 Dec; 17(12):1292-8. PubMed ID: 11773940
[TBL] [Abstract][Full Text] [Related]
16. Induction of PDK4 in the heart muscle of JVS mice, an animal model of systemic carnitine deficiency, does not appear to reduce glucose utilization by the heart.
Ushikai M; Horiuchi M; Kobayashi K; Matuda S; Inui A; Takeuchi T; Saheki T
Mol Genet Metab; 2011 Mar; 102(3):349-55. PubMed ID: 21190881
[TBL] [Abstract][Full Text] [Related]
17. A heterozygote phenotype is present in the jvs +/- mutant mouse livers.
Lahjouji K; Elimrani I; Wu J; Mitchell GA; Qureshi IA
Mol Genet Metab; 2002 May; 76(1):76-80. PubMed ID: 12175785
[TBL] [Abstract][Full Text] [Related]
18. Cardiomegaly in the juvenile visceral steatosis (JVS) mouse is reduced with acute elevation of heart short-chain acyl-carnitine level after L-carnitine injection.
Kuwajima M; Horiuchi M; Harashima H; Lu K; Hayashi M; Sei M; Ozaki K; Kudo T; Kamido H; Ono A; Saheki T; Shima K
FEBS Lett; 1999 Jan; 443(3):261-6. PubMed ID: 10025944
[TBL] [Abstract][Full Text] [Related]
19. Suppressed expression of the urea cycle enzyme genes in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice in infancy and during starvation in adulthood.
Tomomura M; Tomomura A; Musa DA; Horiuchi M; Takiguchi M; Mori M; Saheki T
J Biochem; 1997 Jan; 121(1):172-7. PubMed ID: 9058209
[TBL] [Abstract][Full Text] [Related]
20. The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency.
Nakajima T; Horiuchi M; Yamanaka H; Kizaki Z; Inoue F; Kodo N; Kinugasa A; Saheki T; Sawada T
Pediatr Res; 1997 Jul; 42(1):108-13. PubMed ID: 9212045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]